TAYSHA GENE THERAPIES INC
TSHA · NASDAQ
Updated at 2026-10-13 14:35:20
- Today's High
- $4.14
- Today’s Low
- $3.88
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $4.46
- Previous Close
- $4.14
- Volume
- 4.21M
- Market Cap
- $1.34B
- P/E Ratio
- --
- EPS
- $-0.41
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 3000 PEGASUS PARK DRIVE, DALLAS, TX, UNITED STATES, 75247
- Country
- US
- Listing Date
- 2020-09-24
- Fiscal Year End
- December
- Shares Outstanding
- 319.78M
- CIK
- 0001806310
- Website
- tayshagtx.com
Taysha Gene Therapies, Inc., a gene therapy company, focuses on the development and commercialization of adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. The company is headquartered in Dallas, Texas.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$5.48M
2025-09-30
$0
Operating Expenses
2026-06-30
$47.34M
2026-03-31
$43.19M
2025-12-31
$33.48M
2025-09-30
$33.73M
Net Income
2026-06-30
-$46.63M
2026-03-31
-$42.41M
2025-12-31
-$27.85M
2025-09-30
-$32.73M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
-507.76%
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.13
2026-03-31
$-0.11
2025-12-31
$-0.07
2025-09-30
$-0.09
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$46.34M
2026-03-31
-$42.1M
2025-12-31
-$28M
2025-09-30
-$32.43M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $5.48M | $0 |
| Operating Expenses | $47.34M | $43.19M | $33.48M | $33.73M |
| Net Income | -$46.63M | -$42.41M | -$27.85M | -$32.73M |
| Net Profit Margin | -- | -- | -507.76% | -- |
| Earnings Per Share | $-0.13 | $-0.11 | $-0.07 | $-0.09 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$46.34M | -$42.1M | -$28M | -$32.43M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.